Clinical Trials Sponsored by VM Biopharma
Total 1399 results
-
CTI BioPharmaTerminatedCOVID-19 | COVID | COVID19United States
-
SPARK BiopharmaCompletedPharmacokinetics | Pharmacodynamics | Safety Issues | TolerabilityKorea, Republic of
-
NImmune BiopharmaCompletedUlcerative ColitisUnited States, Bosnia and Herzegovina, Croatia, Poland, Ukraine
-
NImmune BiopharmaWithdrawnEosinophilic Esophagitis
-
NImmune BiopharmaCompletedSafety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female VolunteersNormal Healthy VolunteersUnited States
-
Theravance BiopharmaTerminatedCrohn's DiseaseUnited States, Bulgaria, France, Georgia, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Portugal, Romania, Serbia, South Africa, Spain, Ukraine, Australia, Austria, Croatia, New Zealand, Russian Federation, United...
-
United BioPharmaCompleted
-
Theravance BiopharmaCompletedParkinson Disease | Orthostatic Hypotension | Neurogenic Orthostatic Hypotension | Hypotension, Orthostatic | Pure Autonomic Failure | Multiple System Atrophy (MSA) With Orthostatic Hypotension | Pure Autonomic Failure With Orthostatic Hypotension | Parkinson Disease With Orthostatic HypotensionUnited States
-
Mereo BioPharmaCompletedHypogonadotropic HypogonadismUnited States, Italy, Spain, United Kingdom
-
Theravance BiopharmaCompletedADHD | Attention-Deficit/Hyperactivity DisorderUnited States
-
Theravance BiopharmaCompleted
-
CTI BioPharmaTerminatedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada, France, United Kingdom, Australia, Belgium, Germany, New Zealand, Netherlands, Russian Federation, Hungary, Czechia
-
Theravance BiopharmaCompletedAcute Lung Injury (ALI) Associated With COVID-19 | Inflammatory Lung Conditions Associated With COVID-19United Kingdom
-
Theravance BiopharmaCompletedBowel Diseases, Inflammatory | Intestinal DisorderUnited States
-
Theravance BiopharmaCompleted
-
Theravance BiopharmaCompletedHealthy Adults, Elderly SubjectsUnited States
-
Theravance BiopharmaCompleted
-
Theravance BiopharmaCompletedBowel Diseases, Inflammatory | Intestinal DisordersUnited States
-
Theravance BiopharmaCompletedInflammatory Bowel Diseases | IBDUnited States
-
Theravance BiopharmaCompleted
-
CTI BioPharmaTerminatedProstate CancerUnited States
-
CTI BioPharmaWithdrawn
-
CTI BioPharmaWithdrawnNon-Hodgkin's LymphomaUnited States
-
CTI BioPharmaTerminated
-
Mereo BioPharmaCompletedInteractionUnited States
-
NuSirt BiopharmaCompleted
-
NuSirt BiopharmaCompletedType 2 Diabetes MellitusUnited States
-
NuSirt BiopharmaCompletedType 2 Diabetes MellitusUnited States
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
Recepta BiopharmaTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerBrazil
-
Array BioPharmaTerminatedMelanomaCanada, Spain, Australia, Switzerland, Germany, United States
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
Pronova BioPharmaTerminated
-
Pronova BioPharmaCompleted
-
CTI BioPharmaTerminatedLymphoma, Follicular | Lymphoma, Mixed-Cell, Follicular | Lymphoma, Small Cleaved-Cell, Follicular | Lymphoma, Low-GradeUnited States
-
Theravance BiopharmaCompletedAlzheimer's DiseaseUnited States
-
Array BioPharmaCompletedPancreatic Cancer | Advanced CancerUnited States
-
Limerick BioPharmaWithdrawn
-
CTI BioPharmaCompleted
-
Lantu BiopharmaNot yet recruitingSpinal Muscular Atrophy
-
Huons BiopharmaRecruitingBenign Masseteric HypertrophyKorea, Republic of
-
Cue BiopharmaRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian CancerUnited States
-
Vor BiopharmaRecruitingLeukemia, Myeloid, AcuteUnited States, Canada
-
United BioPharmaRecruiting
-
Vor BiopharmaRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Canada
-
UWELL BiopharmaNot yet recruitingRecurrent Glioblastoma
-
POINT BiopharmaActive, not recruitingSoft Tissue Sarcoma | Colorectal Cancer | Esophageal Cancer | Cholangiocarcinoma | Head and Neck Squamous Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Melanoma (Skin)United States, Canada
-
CTI BioPharmaWithdrawnMetastatic CancerUnited States
-
Mereo BioPharmaCompleted